Purpose of Testing
- Identify the presence of NTRK gene fusion mutations.
- Guide clinicians in selecting appropriate TRK inhibitor therapy.
- Provide treatment options for advanced or refractory tumors.
Discover personalized treatment opportunities through NTRK gene fusion testing. This advanced genetic test identifies tumor responsiveness to modern targeted therapies, ensuring the most effective clinical outcomes for cancer patients.
Scientific name: NTRK Gene Fusion Testing (Pan-Cancer)
A precise genetic test detecting NTRK gene fusions across various tumor types. It identifies candidates for TRK inhibitor therapy, providing effective targeted treatment options regardless of the primary tumor site.